Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Wei

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Molecular and Clinical Oncology|July 24, 2014
Health resource utilisation associated with skeletal-related events in European patients with lung cancer: Α subgroup analysis from a prospective multinational studyVito Lorusso, Ignacio Duran, Cristina Garzon-Rodriguez, et al.
Journal of Clinical Medicine|August 4, 2015
Health Resource Utilization Associated with Skeletal-Related Events in Patients with Advanced Prostate Cancer: A European Subgroup Analysis from an Observational, Multinational StudyAmit Bahl, Herbert Hoefeler, Ignacio Duran, et al.
Springerplus|July 22, 2014
Health resource utilization associated with skeletal-related events in patients with advanced breast cancer: results from a prospective, multinational observational studyDiana Lüftner, Vito Lorusso, Ignacio Duran, et al.
Journal of Medical Internet Research|September 23, 2024
Factors Associated With the Use of Digital Technology Among Youth in Zimbabwe: Findings From a Cross-Sectional Population-Based SurveyKevin Martin, Rachel Wei Chun Peh, Mandikudza Tembo, et al.
Nature Communications|August 9, 2024
Offshore wind and wave energy can reduce total installed capacity required in zero-emissions gridsNatalia Gonzalez, Paul Serna-Torre, Pedro A Sánchez-Pérez, et al.
Blood Advances|June 21, 2021
Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphomaConstantine S Tam, Stephen Opat, David Simpson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 29, 2020
Treatment of Patients with Relapsed or Refractory Mantle-Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine KinaseYuqin Song, Keshu Zhou, Dehui Zou, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Molecular and Clinical Oncology|July 24, 2014
Health resource utilisation associated with skeletal-related events in European patients with lung cancer: Α subgroup analysis from a prospective multinational studyVito Lorusso, Ignacio Duran, Cristina Garzon-Rodriguez, et al.
Journal of Clinical Medicine|August 4, 2015
Health Resource Utilization Associated with Skeletal-Related Events in Patients with Advanced Prostate Cancer: A European Subgroup Analysis from an Observational, Multinational StudyAmit Bahl, Herbert Hoefeler, Ignacio Duran, et al.
Springerplus|July 22, 2014
Health resource utilization associated with skeletal-related events in patients with advanced breast cancer: results from a prospective, multinational observational studyDiana Lüftner, Vito Lorusso, Ignacio Duran, et al.
Journal of Medical Internet Research|September 23, 2024
Factors Associated With the Use of Digital Technology Among Youth in Zimbabwe: Findings From a Cross-Sectional Population-Based SurveyKevin Martin, Rachel Wei Chun Peh, Mandikudza Tembo, et al.
Nature Communications|August 9, 2024
Offshore wind and wave energy can reduce total installed capacity required in zero-emissions gridsNatalia Gonzalez, Paul Serna-Torre, Pedro A Sánchez-Pérez, et al.
Blood Advances|June 21, 2021
Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphomaConstantine S Tam, Stephen Opat, David Simpson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 29, 2020
Treatment of Patients with Relapsed or Refractory Mantle-Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine KinaseYuqin Song, Keshu Zhou, Dehui Zou, et al.
Pageof 2